Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 9 | Longs Won 7/9 77% | Profit Factor 0.98 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $9,480.54 |
| Average Win $3,361.93 | Best Trade (Mar 21) $13,095.47 | Sharpe Ratio -40.49 |
| Average Loss -$12,023.55 | Worst Trade (Nov 20) -$22,406.82 | Z-Score 1.53 (87.47%) |
| Commissions $0 | Avg. Trade Length 1m 4w | Expectancy $34.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | 84.3% | 88.75% | 91.46% | 93.43% | 94.99% | 96.28% | 97.39% | 98.36% | 99.22% |
| Consecutive Losing Trades | 8 | 8 | 7 | 6 | 5 | 4 | 3 | 3 | 2 | 1 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 79.94 | $93,545.98 | $100,314.06 | - | $6,768.08 | 7.24% | +0.255% |